Treatment effects of fampridine on ambulation and upper extremity function in patients with multiple sclerosis from a real-world evidence cohort

被引：0
|
作者：
Kaya, L. [1 ]
van Munster, C. E. P. [1 ]
Lam, K. -H. [1 ]
Kalkers, N. F. [1 ]
Killestein, J. [1 ]
Uitdehaag, B. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam Neurosci, VUmc MS Ctr Amsterdam, Dept Neurol, Amsterdam, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1261
引用
收藏
页码：720 / 721
页数：2
相关论文
共 50 条
  • [1] Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
    Rodriguez-Leal, Francisco Alejandro
    Haase, Rocco
    Akguen, Katja
    Eisele, Judith
    Proschmann, Undine
    Schultheiss, Thorsten
    Kern, Raimar
    Ziemssen, Tjalf
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10 : 1 - 11
  • [2] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Ofir Zmira
    Alex I. Halpern
    Lital Abraham
    Anat Achiron
    Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
  • [3] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
    Zmira, Ofir
    Halpern, Alex, I
    Abraham, Lital
    Achiron, Anat
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
  • [4] Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis
    Regner-Nelke, Liesa
    Pawlitzki, Marc
    Willison, Alice
    Rolfes, Leoni
    Oezalp, Sinem-Hilal
    Nelke, Christopher
    Koelsche, Tristan
    Korsen, Melanie
    Grothe, Matthias
    Groppa, Sergiu
    Luessi, Felix
    Engel, Sinah
    Nelles, Gereon
    Bonmann, Eckhard
    Roick, Holger
    Friedrich, Anke
    Knorn, Philipp
    Landefeld, Harald
    Biro, Zoltan
    Ernst, Michael
    Bayas, Antonios
    Menacher, Martina
    Akgun, Katja
    Kleinschnitz, Christoph
    Ruck, Tobias
    Ziemssen, Tjalf
    Pul, Refik
    Meuth, Sven G.
    NEUROLOGICAL RESEARCH AND PRACTICE, 2022, 4 (01):
  • [5] Real-world evidence of ocrelizumab in Chilean patients with multiple sclerosis
    del Canto, Adolfo
    Carcamo, Claudia
    Garcia, Lorena
    Aylwin, Ester
    Jurgensen-Heinrich, Lukas
    Guzman-Carcamo, Ignacio
    de la Barra, Juan
    Gutierrez-Calquin, Leticia
    Barrera-Hormazabal, Antonia
    Cruz, Juan Pablo
    Bravo, Sebastian
    Pelayo, Carolina
    Soler, Bernardita
    Uribe-San-Martin, Reinaldo
    Ciampi, Ethel
    MULTIPLE SCLEROSIS JOURNAL, 2025,
  • [6] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [7] Gait quality and function after fampridine treatment in patients with multiple sclerosis - A prospective cohort study
    Thorning, Maria
    Nielsen, Helle Hvilsted
    Frich, Lars Henrik
    Jensen, Henrik Boye
    Lambertsen, Kate Lykke
    Holsgaard-Larsen, Anders
    CLINICAL BIOMECHANICS, 2022, 100
  • [8] Effectiveness and safety of dimethyl fumarate treatment in relapsing multiple sclerosis patients: Real-world evidence
    Alroughani R.
    Ahmed S.F.
    Behbehani R.
    Al-Hashel J.
    Neurology and Therapy, 2017, 6 (2) : 189 - 196
  • [9] Effectiveness and safety of dimethyl fumarate treatment in patients with relapsing multiple sclerosis: A real-world evidence
    Alroughani, Raed
    Ahmed, Samar
    Behbehani, Raed
    Al-hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP17 - NP17
  • [10] Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis
    Nils-Henning Ness
    Dirk Schriefer
    Rocco Haase
    Benjamin Ettle
    Tjalf Ziemssen
    PharmacoEconomics, 2020, 38 : 883 - 892
12345